Stock Hero Advertisement SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

Tekmira Pharmaceuticals Corporation (TKMR)

Add TKMR Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator mick, nanopatent, KarinCA
Search This Board:
Last Post: 4/25/2015 3:38:04 PM - Followers: 113 - Board type: Free - Posts Today: 0

Tekmira Pharmaceuticals Corporation








Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201


As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.




Important Company Highlights: 

LNP Delivery Platform

Tekmira’s Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date. Administered intravenously, our LNP delivery technology allows RNAi drugs to be encapsulated in tiny particles made of lipids (fats or oils). These tiny particles – LNP – travel through the bloodstream to target tissues.





Recent News:





Links of importance for those that trade Canadian stocks:




 CNW Group Newswire:

Canadian Insider:

Currency Converter:


Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

Share Structure:   See filings

Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 Currency Converter:





 All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
Option Chain for TKMR
TKMR News: Tekmira Conference Call and Webcast Advisory Corporate Update and First Quarter Financial Results 04/22/2015 07:00:00 PM
TKMR News: Current Report Filing (8-k) 04/22/2015 03:36:05 PM
TKMR News: Tekmira and Collaborators Publish Positive Preclinical Ebola Survival Data in Nature Journal 04/22/2015 02:13:04 PM
TKMR News: Tekmira Pharmaceuticals Raised to "Strong-Buy" at Vetr Inc. (TKMR) 04/15/2015 08:03:59 PM
TKMR News: Tekmira's Ebola vaccine candidate cleared for repeat dosing in Phase 1 study 04/10/2015 09:45:22 AM
#1088  Sticky Note TKMR – Tekmira Pharmaceuticals Corp News, Filings and misc: KarinCA 08/10/14 01:52:25 AM
#4853 mick 04/25/15 03:38:04 PM
#4852   ....thank you KarinCA for keeping us informed here.I wsgalvanize 04/24/15 10:23:39 AM
#4851   The is the part many don't realize: KarinCA 04/24/15 01:08:39 AM
#4850   Alnylam (ALNY)'s Phase II Study Confirms Effectiveness of nanopatent 04/21/15 01:41:07 PM
#4848   The Tekmira drug isn't a vaccine. And, KarinCA 04/17/15 01:41:07 PM
#4847   Just thinking; is a vaccine a drug? nanopatent 04/17/15 01:10:24 PM
#4846   Tekmira Pharmaceuticals Upgraded by Vetr Inc. to $30 nanopatent 04/17/15 01:04:54 PM
#4845   It's not a vaccine. It's a therapeutic. KarinCA 04/15/15 06:42:21 PM
#4844   is this good ?????/ TKMR News: Tekmira's Ebola mick 04/15/15 05:22:44 PM
#4843   Tekmira Pharmaceutic (TKMR) mick 04/15/15 05:21:59 PM
#4842   Tekmira's Ebola vaccine candidate cleared for repeat dosing KarinCA 04/10/15 11:29:42 AM
#4841 mick 04/07/15 03:03:51 AM
#4840   Tekmira Pharmaceuticals Receives New Coverage from Analysts at nanopatent 03/31/15 09:12:33 AM
#4839   Tekmira Pharmaceuticals Receives New Coverage from Analysts at nanopatent 03/31/15 09:11:12 AM
#4838   $TKMR - Analyst ratings: KarinCA 03/29/15 04:46:30 PM
#4837   Tekmira Pharmaceuticals Upgraded by Vetr Inc. to “Strong-Buy” (TKMR) nanopatent 03/26/15 09:30:32 AM
#4836   Tekmira Presents Preclinical Results Demonstrating Super-Additive Effects on John-Knee 03/25/15 09:44:40 PM
#4835,uu[305,a]dacayaci[pb20!b50][dg mick 03/24/15 04:15:08 PM
#4834   Tekmira Pharmaceutic (TKMR) mick 03/18/15 01:37:45 AM
#4833   Mommy, how high is the sky?? nanopatent 03/16/15 07:18:25 PM
#4832   American who contracted Ebola now in critical condition Echo20 03/16/15 05:01:19 PM
#4831   Americans returning from Africa for Ebola monitoring Echo20 03/14/15 09:41:54 PM
#4830   Tekmira - the sky is the limit! nanopatent 03/11/15 02:06:08 PM
#4829   $TKMR - Trial of Tekmira's TKM-Ebola treatment starts KarinCA 03/11/15 01:12:01 PM
#4828[ mick 03/07/15 12:03:55 AM
#4827   Fighting the 50 day right now. Get a jamezz23 03/05/15 10:44:28 AM
#4826   Good to see you here too, mick. Been EF5$tocks 03/05/15 08:55:41 AM
#4825   Tekmira Pharmaceuticals Corp Price Target Update nanopatent 03/04/15 09:13:18 PM
#4824   good stuff/ vote to ratify merger ????? t.b.a/ mick 03/04/15 12:56:22 AM
#4823   99.5% of Tekmira Shareholders Vote in Favor of John-Knee 03/04/15 12:33:08 AM
#4822   Looking like she might want to move up jamezz23 03/03/15 06:41:41 PM
#4821   Reports on the 500 doses of TKMR EBOLA Echo20 02/27/15 10:12:13 AM
#4820 mick 02/25/15 01:35:56 PM
#4819   Support is broken Dr_Thorfin 02/25/15 12:21:12 PM
#4818   TKMR Tekmira Pharmaceuticals Corporation mick 02/23/15 07:57:19 PM
#4817   Overviews are great. nanopatent 02/23/15 08:31:08 AM
#4816   tomorrow we have a company overview at the Dr_Thorfin 02/23/15 06:43:12 AM
#4815   few weeks of consollidation after that huge jump Dr_Thorfin 02/21/15 06:23:12 AM
#4814   Ready to bounce Dr_Thorfin 02/20/15 05:59:54 PM
#4813   Tekmira Pharmaceuticals Corporation Analyst Rating Update nanopatent 02/20/15 03:52:31 PM
#4812   bounce of MA50 ?? Dr_Thorfin 02/20/15 10:46:41 AM
#4811   Current Report Filing (8-k) "Edgar (US Regulatory)" - mick 02/13/15 01:46:13 PM
#4810   Tekmira Pharmaceutic (TKMR) mick 02/13/15 01:45:18 PM
#4809   Tekmira Pharmaceuticals Corporation (TKMR) mick 02/13/15 01:44:34 PM
#4808   Gilead ( GILD) Agrees to a Discounted Price nanopatent 02/13/15 10:14:52 AM
#4807   Tekmira Announces Filing of Definitive Proxy Statement and John-Knee 02/04/15 10:21:26 PM
#4806   Is news nearby? muggel 02/04/15 11:01:40 AM
#4805 muggel 02/04/15 07:59:20 AM
#4804 mick 02/03/15 01:20:06 PM
#4803   On the technical charting; support levels are 23.30, John-Knee 02/03/15 10:37:14 AM